Science Explorer Interactive view Map
Company · Yokohama · Japan

DNA Chip Research (Japan)

dna-chip.co.jpROR OpenAlex
Research works
64
▲ 47% vs 2013–17
Citations
1.9k
29.1 per fractional work
Top-10% rate
9.5%
record average 16.5%
Open access
59%
world 28%

Not ranked overall: DNA Chip Research (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.76× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.23× its world share, 1 worksImmunology and Micro…Computer Science: 0.07× its world share, 0 worksComputer ScienceEnergy: 2.30× its world share, 0 worksEnergyHealth Professions: 0.52× its world share, 0 worksHealth ProfessionsMedicine: 3.61× its world share, 11 worksMedicineNursing: 0.54× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.

Which keywords describe research at DNA Chip Research (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Inflammation, Gene Expression, Autoantibodies, Chemotherapy, Cancer, Clinical Trials and Treatment Guidelines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation8▲ 5.2×22 topics
  2. Targeted Therapy7▲ 49×3 topics
  3. Cancer5▲ 5.5×17 topics
  4. Gene Expression4▲ 11×9 topics
  5. Autoantibodies4▲ 29×7 topics
  6. Chemotherapy4▲ 9.5×8 topics
  7. Clinical Trials4▲ 9.6×2 topics
  8. Treatment Guidelines4▲ 28×3 topics
  9. ALK Inhibitors3▲ 85×1 topic
  10. Cell-Free DNA3▲ 51×2 topics
  11. EGFR Mutations3▲ 85×1 topic
  12. Somatic Mutations3▲ 72×2 topics
  13. Cancer Genomics3▲ 83×1 topic
  14. Mutational Signatures3▲ 83×1 topic
  15. Adjuvant Therapy2▲ 34×2 topics
  16. Insulin Resistance2▲ 7.6×4 topics
  17. Treatment2▲ 2.8×7 topics
  18. Cardiovascular Disease2▲ 3.0×6 topics
  19. Data Analysis2▲ 10×2 topics
  20. Normalization2▲ 46×2 topics
  21. Obesity2▲ 4.5×6 topics
  22. Metabolic Syndrome2▲ 3.9×7 topics
  23. Cancer Risk2▲ 12×3 topics
  24. Metastasis2▲ 9.4×6 topics
  25. Tumor Microenvironment2▲ 8.3×5 topics
  26. Biomarkers2▲ 4.5×3 topics
  27. Endothelial Dysfunction2▲ 9.5×2 topics
  28. Molecular Characterization2▲ 15×3 topics
  29. Radiotherapy2▲ 7.5×2 topics
  30. CT Screening2▲ 49×1 topic
  31. Cytokines2▲ 9.8×3 topics
  32. Lung Cancer2▲ 16×1 topic
  33. Innate Immunity2▲ 6.9×6 topics
  34. Metabolic Regulation2▲ 8.8×3 topics
  35. Biological Therapy1▲ 38×1 topic
  36. Immunosuppressive Therapy1▲ 12×3 topics
  37. Macrophages1▲ 13×3 topics
  38. Rheumatoid Arthritis1▲ 21×1 topic
  39. TGF-ß Signaling1▲ 32×3 topics
  40. Autoimmunity1▲ 10×3 topics

Which research topics does DNA Chip Research (Japan) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics and Lung Cancer Research Studies.

Lung Cancer Treatments a…3Lung Cancer Treatments and Mutations: 3 fractional worksLung Cancer Diagnosis and Treatment: 2 fractional worksCancer Genomics and Diagnostics: 2 fractional worksLung Cancer Research Stu…1Lung Cancer Research Studies: 1 fractional worksInflammatory Myopathies …1Inflammatory Myopathies and Dermatomyositis: 1 fractional worksRheumatoid Arthritis Res…0Rheumatoid Arthritis Research and Therapies: 0 fractional worksNeutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksSystemic Lupus Erythematosus Research: 0 fractional worksGenetic factors in colorectal cancer: 0 fractional worksAlgal biology and biofuel production: 0 fractional works
Pulmonary and Respiratory MedicineCancer ResearchOncologyEpidemiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  2. 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 2 works
  4. 4 Lung Cancer Research Studies Oncology 1 works
  5. 5 Inflammatory Myopathies and Dermatomyositis Epidemiology 1 works
  6. 6 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  7. 7 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  8. 8 Systemic Lupus Erythematosus Research Rheumatology 0 works
  9. 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  10. 10 Algal biology and biofuel production Renewable Energy, Sustainability and the Environment 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.2%not open40.8%

World: 28% of research is openly available.

with international co-authors10.3%domestic only89.7%

World: 19% is written across borders.

How has DNA Chip Research (Japan)'s research output changed?

Output in 2018–2022 was 47% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Yokohama

All research institutions in Yokohama

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.